Literature detail

Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021.

Maya Holding1,2 Ashley David Otter3 Stuart Dowall1 Katsuhisa Takumi4 Bethany Hicks3 Tom Coleman3 Georgia Hemingway3 Matthew Royds3 Stephen Findlay-Wilson1 Mollie Curran-French1 Richard Vipond1,2 Hein Sprong4 Roger Hewson1,2,5
Affiliations 5 institutions
  1. Virology and Pathogenesis Group, UK Health Security Agency, Porton Down, Salisbury, UK.
  2. Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.
  3. SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton Down, Salisbury, UK.
  4. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  5. Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
PMID 35338581 2022 Transbound Emerg Dis eng ppublish
PubMed DOI Browse context

Article

Publication summary

Following findings in Northern America of SARS-CoV-2 infections in white-tailed deer, there is concern of similar infections in European deer and their potential as reservoirs of SARS-CoV-2 including opportunities for the emergence of new variants. UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing. There is no evidence that spill-over infections of SARS-CoV-2 occurred from the human population to UK deer or that SARS-CoV-2 has been circulating in UK deer (over the study period). Although it cannot be ruled out, study results indicate that spill-over infections followed by circulation of SARS-CoV-2 to the most common European deer species is small.

COVID-19 serological testing deer SARS-CoV-2 sentinel surveillance United Kingdom viral zoonoses COVID-19 Deer Animals Animals, Wild Antibodies, Viral COVID-19 Testing Humans SARS-CoV-2 Spike Glycoprotein, Coronavirus spike protein, SARS-CoV-2

Structured evidence records

Evidence records

2 total
1 records
Extraction confidence 0.98
Key finding

Wild deer in the United Kingdom showed no serological evidence of exposure to SARS-CoV-2 based on serology and neutralization testing.

Virus
Host
Location
Not specified
Supporting text

UK deer sera were collected in 2020–2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing.

Method
anti-spike serology assay; anti-nucleocapsid serology assay; surrogate neutralization testing
Sample type
sera
1 records
Extraction confidence 0.95
Key finding

Serological surveillance of United Kingdom wild deer in 2020–2021 found no evidence of SARS-CoV-2 exposure.

Virus
Host
Location
Supporting text

UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing.

Method
anti-spike serology assay; anti-nucleocapsid serology assay; surrogate neutralization testing
Sample type
sera
Geographic raw
United Kingdom
Country inferred
United Kingdom